Partial purification of type A and B flagellin from Pseudomonas aeruginosa for preclinical use
Keywords:
Pseudomonas aeruginosa, Flagellin, Purification, Endotoxin Removal, Endotoxin detection, fliC geneAbstract
Background: Due to their importance in vaccination, we tried in this study to purify the flagellin type a and type b separately from P. aeruginosa by a simple and cheap method with acceptable purity for preclinical use. Methods: Specific primer was used to detect the type a and b flagellin gene (fliC gene) in P. aeruginosa clinical isolates. Flagellin was purified from P. aeruginosa according to standard procedure with some modifications. Protein concentration and protein absorption were measured using a special spectrophotometer at 270 wavelength. Endotoxin removal was done using a special column. Then, the presence of flagellin was detected by SDS-PAGE. Results: The results showed two types of flagllin genes in different strains; type a (1020 bp) and type b (1250 pb) that amplified by PCR. Results also showed an appropriate concentration of purified protein by the used method with acceptable purity and decreasing the endotoxin to an acceptable level for preclinical use (less than 2.2 EU/ml). Conclusion: This research focused on the isolation and purification of flagellin protein from P. aeruginosa.
Downloads
References
Al Charrakh AH, Al Awadi SJ, Mohammed AS. Detection of metallo-β-lactamase producing Pseudomonas aeruginosa isolated from public and private hospitals in Baghdad, Iraq. 2016;
Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature. 2001;
Ertugrul BM, Oryasin E, Lipsky BA, Willke A. Virulence genes fliC , toxA and phzS are common among Pseudomonas aeruginosa isolates from diabetic foot infections Virulence genes fliC , toxA and phzS are common among Pseudomonas aeruginosa isolates from diabetic foot infections. Infect Dis (Auckl). 2017;0(0):1–7.
Prince A. Flagellar activation of epithelial signaling. Am J Respir Cell Mol Biol. 2006;34(5):548–51.
Zhang Y, Deng Q, Barbieri JT. Intracellular localization of type III-delivered Pseudomonas ExoS with endosome vesicles. J Biol Chem. 2007;282(17):13022–32.
Beaudoin T, LaFayette S, Roussel L, Bérubé J, Desrosiers M, Nguyen D, et al. The level of p38$α$ mitogen-activated protein kinase activation in airway epithelial cells determines the onset of innate immune responses to planktonic and biofilm Pseudomonas aeruginosa. J Infect Dis. 2013;207(10):1544–55.
Descamps D, Le Gars M, Balloy V, Barbier D, Maschalidi S, Tohme M, et al. Toll-like receptor 5 (TLR5), IL-1β secretion, and asparagine endopeptidase are critical factors for alveolar macrophage phagocytosis and bacterial killing. Proc Natl Acad Sci U S A. 2012;
Wei H-L, Chakravarthy S, Worley JN, Collmer A. Consequences of flagellin export through the type III secretion system of P seudomonas syringae reveal a major difference in the innate immune systems of mammals and the model plant N icotiana benthamiana. Cell Microbiol. 2013;15(4):601–18.
Ince D, Sutterwala FS, Yahr TL. Secretion of flagellar proteins by the Pseudomonas aeruginosa type III secretion-injectisome system. J Bacteriol. 2015;197(12):2003–11.
Amiel E, Lovewell RR, O’Toole GA, Hogan DA, Berwin B. Pseudomonas aeruginosa evasion of phagocytosis is mediated by loss of swimming motility and is independent of flagellum expression. Infect Immun. 2010;78(7):2937–45.
Zare A, Keshavarzmehr M, Afshar Z, Aleyasin N, Banadkoki AZ, Keshavarzmehr M, et al. Protective effect of pilin protein with alum+naloxone adjuvant against acute pulmonary Pseudomonas aeruginosa infection. Biologicals. 2016 Sep;44(5):367–73.
Korpi F, Hashemi FB, Irajian G, Fatemi MJ, Laghaei P, Behrouz B. Flagellin and pilin immunization against multi-drug resistant Pseudomonas aeruginosa protects mice in the burn wound sepsis model. Immunol Lett. 2016 Aug;176:8–17.
Behrouz B, Hashemi FB, Fatemi MJ, Naghavi S, Irajian G, Halabian R, et al. Immunization with bivalent flagellin protects mice against fatal Pseudomonas aeruginosa pneumonia. J Immunol Res. 2017;2017:1–17.
Allison JS, Dawson M, Drake D, Montie TC. Electrophoretic separation and molecular weight characterization of Pseudomonas aeruginosa H-antigen flagellins. Infect Immun. 1985;49(3):770–4.
Faezi S, Safarloo M, Amirmozafari N, Nikokar I, Siadat SD, Holder IA, et al. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection. Apmis. 2014;122(2):115–27.
Forbes BA, Sahm DF, Weissfeld AS, others. Diagnostic microbiology. Mosby St Louis; 2007.
Khani MH, Bagheri M. Introducing a cost-effective method for purification of bioactive flagellin from several flagellated gram-negative bacteria. Protein Expr Purif. 2018;155:48–53.
Thermo. Pierce TM Protein Concentrators , PES. USA; 2019.
Needham BD, Trent MS. Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis. Nat Rev Microbiol. 2013;11(7):467–81.
Brito LA, Singh M. COMMENTARY: Acceptable Levels of Endotoxin in Vaccine Formulations During Preclinical Research. J Pharm Sci. 2011 Jan;100(1):34–7.
Pierce High-Capacity Endotoxin Removal Resin. USA; Available from: https://assets.thermofisher.com/TFS-Assets/LSG/manuals/MAN0016351_2162373_PierceHighCapacityEndotoxRemovalResin_UG.pdf
Pierce Chromogenic Endotoxin Quant Kit. USA; 2018.
Chromogenic P, Quant E, Endotoxin C, Kit Q. A highly sensitive assay for endotoxin detection and quantitation for a variety of sample types.
Chang SKC, Zhang Y. Protein Analysis. In: Nielsen SS, editor. Food Analysis . Cham: Springer International Publishing; 2017. p. 315–31.
Verma A, Schirm M, Arora SK, Thibault P, Logan SM, Ramphal R. Glycosylation of b-type flagellin of Pseudomonas aeruginosa: Structural and genetic basis. J Bacteriol. 2006;188(12):4395–403.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.








